To be selected for the list, businesses had to demonstrate not only positive revenue growth over the last three years but also outperform their sector peers
Genmed has been identified as one of London Stock Exchange Group’s 1000 Companies to Inspire Britain for the second year running. Published annually, the '1000 Companies to Inspire Britain' report celebrates the UK’s fastest-growing and most dynamic small and medium sized businesses (SMEs), with companies representing over 40 sectors and spanning every region of the country.
To be selected for the list, businesses had to demonstrate not only positive revenue growth over the last three years but also outperform their sector peers. The result is a unique and varied list of the UK’s most innovative companies - SMEs which are the engine and future of the British economy. The report showcases the depth and breadth of high growth businesses in the UK.
Rt Hon Nicky Morgan MP said, "SMEs in the UK have huge potential for growth, huge potential to provide high quality jobs and huge potential to provide a greater distribution of wealth and economic success across the length and breadth of our country. Speaking as chair of the treasury select committee, we have recently launched an inquiry into the regional economic in-balances that exist in the UK and so it fills me with great encouragement that 70% of the 1000 businesses featured in today’s report are based outside London. The nation as a whole is going to be better served if every region in the UK has innovative, highly skilled workplaces around which vibrant and dynamic regional economies can be built."
With office locations in Wales and Weybridge, Genmed provides vendor neutral managed services in the NHS which help Trusts to reduce costs, rationalise pricing, improve efficiency, enhance clinical productivity, speed up purchasing, minimise administration and invoice processing. Genmed’s managed services are HMRC compliant for VAT recovery which means Trusts can reclaim the 20% VAT to re-invest in front line services and the treatment of patients.
Genmed has developed from initially delivering pathology contracts to now managing contracts which encompass surgery, pathology, flexible endoscopy, IT, radiology, electronic medical records management and renal. It is also able to provide building contracts including finance up to PFI level.
Genmed ... is an integral partner working with Trusts to ascertain what clinical facilities or technology they need
David Schwimmer, London Stock Exchange Group’s CEO, said, "Congratulations to all the companies selected for inclusion in the sixth edition of London Stock Exchange Group’s 1000 Companies to Inspire Britain report, which identifies the UK’s most dynamic SMEs. SMEs drive growth, innovation and job creation and are the lifeblood of the British economy. We believe that supporting the growth of these businesses is critical to the UK and the creation of a society that works for everyone."
Genmed is not a managed equipment provider or a finance house. Providing a much wider and more central role, it is an integral partner working with Trusts to ascertain what clinical facilities or technology they need, their workload issues, finding and selecting suppliers, driving product costs down, putting together the finance, managing the contracts, paying subcontractors and taking all the risk upfront itself. Importantly, Genmed is not tied to any third-party suppliers and selects consumables and equipment based on close collaboration and input from NHS managers and clinicians.
Genmed now works for 40 NHS Trusts throughout the UK including: